(Q38346472)

English

A whole genome transcriptional analysis of the early immune response induced by live attenuated and inactivated influenza vaccines in young children.

scientific article published on 12 February 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153794%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

A whole genome transcriptional analysis of the early immune response induced by live attenuated and inactivated influenza vaccines in young children (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153794%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

attenuated vaccine

1 reference

based on heuristic

inferred from title

influenza vaccine

1 reference

based on heuristic

inferred from title

whole genome sequencing

1 reference

based on heuristic

inferred from title

Christopher S Ambrose

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153794%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Brandon W. Higgs

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153794%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Wei Zhu

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153794%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Chris Morehouse

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153794%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Katie Streicher

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153794%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Jennifer Woo

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153794%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

George W Kemble

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153794%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Bahija Jallal

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153794%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Yihong Yao

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153794%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

0 references

publication date

12 February 2010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153794%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153794%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

28

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153794%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153794%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

2865-2876

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153794%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Superior Relative Efficacy of Live Attenuated Influenza Vaccine Compared With Inactivated Influenza Vaccine in Young Children With Recurrent Respiratory Tract Infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Live attenuated versus inactivated influenza vaccine in infants and young children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Emerging data on the safety and efficacy of influenza vaccines in children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Phenotypic Changes in Influenza‐Specific CD8+T Cells after Immunization of Children and Adults with Influenza Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Innate immune modulation by RNA viruses: emerging insights from functional genomics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Analysis of gene-expression profiles by oligonucleotide microarray in children with influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Gene expression profiles during in vivo human rhinovirus infection: insights into the host response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

How cells respond to interferons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Gene expression patterns in blood leukocytes discriminate patients with acute infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Integrated molecular signature of disease: analysis of influenza virus-infected macaques through functional genomics and proteomics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Application of DNA microarray technology to influenza A/Vietnam/1194/2004 (H5N1) vaccine safety evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Pvclust: an R package for assessing the uncertainty in hierarchical clustering.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Combining evidence using p-values: application to sequence homology searches

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Type I interferon: potential therapeutic target for psoriasis?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Gene expression profiles during human CD4+ T cell differentiation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

E2F target genes: unraveling the biology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

GATA transcription factors directly regulate the Parkinson's disease-linked gene alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional control

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

NUP98-HOXA9 induces long-term proliferation and blocks differentiation of primary human CD34+ hematopoietic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Forensic genetics and ethical, legal and social implications beyond the clinic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

An overview of the interferon system: signal transduction and mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Transcriptional regulation of interferon-stimulated genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

BAL1 and BBAP are regulated by a gamma interferon-responsive bidirectional promoter and are overexpressed in diffuse large B-cell lymphomas with a prominent inflammatory infiltrate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

An Atomic Model of the Interferon-β Enhanceosome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Molecular stop signs: regulation of cell-cycle arrest by C/EBP transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Th1 memory: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Intranasal administration of alpha interferon reduces seasonal influenza A virus morbidity in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

The role of differential expression of human interferon--a genes in antiviral immunity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

The natural alliance between type I interferon and dendritic cells and its role in linking innate and adaptive immunity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Type I interferon as a link between innate and adaptive immunity through dendritic cell stimulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.060

7 January 2021

Identifiers

10.1016/J.VACCINE.2010.01.060

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153794%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153794%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38346472&oldid=2149066772"